Why CAVA Stock Is Down Today | Quiver Quantitative

CAVA Group (CAVA) is down 5.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of lingering food-safety-related demand concerns, pressure on margin expectations, and a still-premium valuation that has left the stock sensitive to any sign of slowing momentum. There does not appear to be a fresh company announcement today, so the drop may reflect investors continuing to reprice the shares after August commentary on softer produce-related demand and recent analyst target cuts.

Details:

CAVA’s second-quarter 2026 results were strong on revenue and same-restaurant sales, but the company kept its full-year outlook unchanged rather than raising it.

Management said in August that broader consumer concerns around leafy greens and fresh produce had weighed on sales near the end of the quarter, even though CAVA said it was not directly implicated in the outbreak tied to iceberg lettuce.

The quarter also showed restaurant-level margin pressure from higher input costs tied to menu innovation, a higher mix of third-party delivery, and wage investments.

Recent analyst target cuts suggest some on Wall Street are bracing for near-term volatility as investors weigh traffic resilience, margin recovery, and whether the stock’s valuation still supports a premium multiple.

Sources:

CAVA Investor Relations, SEC, CDC, Benzinga, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CAVA Insider Trading Activity

$CAVA insiders have traded $CAVA stock on the open market 17 times in the past 6 months. Of those trades, 5 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $CAVA stock by insiders over the last 6 months:

PARTICIPATIONS S.A R.L. ARTAL sold 3,000,000 shares for an estimated $270,900,000
BRETT SCHULMAN (CEO and President) sold 33,174 shares for an estimated $2,966,750
KELLY COSTANZA (Chief People Officer) has made 0 purchases and 3 sales selling 25,370 shares for an estimated $2,180,262.
DOUGLAS W. THOMPSON (Chief Operations Officer) has made 3 purchases buying 13,000 shares for an estimated $944,930 and 0 sales.
KAREN KOCHEVAR sold 10,000 shares for an estimated $900,000
ADAM DAVID PHILLIPS (Chief Accounting Officer) has made 0 purchases and 4 sales selling 10,602 shares for an estimated $890,432.
TRICIA K. TOLIVAR (Chief Financial Officer) sold 4,969 shares for an estimated $444,377
THEODOROS XENOHRISTOS (Chief Concept Officer) sold 3,252 shares for an estimated $290,826
JOSEPH JOHN KADOW (CLO & Secretary) has made 2 purchases buying 2,000 shares for an estimated $149,000 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CAVA Hedge Fund Activity

We have seen 245 institutional investors add shares of $CAVA stock to their portfolio, and 320 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS removed 4,693,223 shares (-76.5%) from their portfolio in Q2 2026, for an estimated $368,324,141
ARTAL GROUP S.A. removed 3,000,000 shares (-31.6%) from their portfolio in Q2 2026, for an estimated $235,440,000
ALLIANCEBERNSTEIN L.P. removed 2,543,018 shares (-27.7%) from their portfolio in Q2 2026, for an estimated $199,576,052
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,274,228 shares (-52.7%) from their portfolio in Q2 2026, for an estimated $100,001,413
COOPER CREEK PARTNERS MANAGEMENT LLC removed 1,149,188 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $92,969,309
CAPITAL WORLD INVESTORS removed 1,105,056 shares (-52.0%) from their portfolio in Q2 2026, for an estimated $86,724,794
1832 ASSET MANAGEMENT L.P. added 1,006,300 shares (+66.2%) to their portfolio in Q2 2026, for an estimated $78,974,424

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CAVA Analyst Ratings

Wall Street analysts have issued reports on $CAVA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Argus Research issued a "Buy" rating on 05/22/2026
TD Cowen issued a "Buy" rating on 05/20/2026

To track analyst ratings and price targets for $CAVA, check out Quiver Quantitative's $CAVA forecast page.

$CAVA Price Targets

Multiple analysts have issued price targets for $CAVA recently. We have seen 19 analysts offer price targets for $CAVA in the last 6 months, with a median target of $95.0.

Here are some recent targets:

Lynne Collier from Freedom Capital Markets set a target price of $95.0 on 07/01/2026
Dennis Geiger from UBS set a target price of $90.0 on 06/10/2026
Andrew M. Charles from TD Cowen set a target price of $100.0 on 06/04/2026
Matt Curtis from DA Davidson set a target price of $84.0 on 05/21/2026
Brian Harbour from Morgan Stanley set a target price of $86.0 on 05/20/2026
Brian Mullan from Piper Sandler set a target price of $92.0 on 05/20/2026
An analyst from Roth Capital set a target price of $106.0 on 05/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.